Literature DB >> 1512469

Immunomorphologic and biochemical identification of the pemphigus foliaceous autoantigen within desmosomes.

K Rappersberger1, N Roos, J R Stanley.   

Abstract

Desmosomes are specialized domains of the plasma membrane that play a fundamental role in intercellular adhesion. This adhesive function is mediated at least in part by the cadherin homologous cell adhesion molecule (CAM) desmoglein (dg). Autoantibodies (aab) from patients with pemphigus foliaceous (pf), a blistering disease of the epidermis, have been shown by immunochemical methods to bind to desmoglein. However, the molecular localization of the binding sites of these antibodies, especially as it relates to the ultrastructure of the desmosomes, has not been definitively characterized. We therefore performed pre-embedding direct immunoelectron microscopy (IEM) on perilesional skin of patients with pf and post-embedding indirect IEM using sera from five patients with pf. We first confirmed by immunoprecipitation and immunoblotting that these sera bound dg. Both IEM methods showed that pf-aab exclusively bind to desmosomes. Double-labeling IEM of several other constitutive desmosomal proteins further suggests that most likely pf-aab bind to an extracellular domain of the transmembrane CAM dg. Our studies suggest one possible pathophysiologic mechanism for the clinical manifestations of pf: namely, that the binding of aab to an extracellular epitope of desmoglein might impair the adhesive properties of desmosomes mediated by dg and result in the loss of cell adhesion leading to acantholysis and blister formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512469     DOI: 10.1111/1523-1747.ep12616659

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Binding of autoantibodies is not restricted to desmosomes in pemphigus vulgaris: comparison of 14 cases of pemphigus vulgaris and 10 cases of pemphigus foliaceus studied by western immunoblot and immunoelectron microscopy.

Authors:  C Bédane; C Prost; E Thomine; L Intrator; P Joly; F Caux; M Blecker; P Bernard; M J Leboutet; F Tron; P Lauret; J M Bonnetblanc; L Dubertret
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

2.  Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus.

Authors:  E Cozzani; J Kanitakis; J F Nicolas; D Schmitt; J Thivolet
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases.

Authors:  F Batteux; N Franck; P Jaffray; M Raulo; C Prost; M Leibowitch; J P Escande; B Weill
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

4.  Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.

Authors:  M G Mahoney; Z Wang; K Rothenberger; P J Koch; M Amagai; J R Stanley
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

5.  The Thomsen-Friedenreich antigen-binding lectin jacalin interacts with desmoglein-1 and abrogates the pathogenicity of pemphigus foliaceus autoantibodies in vivo.

Authors:  Ning Li; Moonhee Park; Minglang Zhao; Julio Hilario-Vargas; David M McInnes; Phillip S Prisayanh; Zhi Liu; Luis A Diaz
Journal:  J Invest Dermatol       Date:  2010-07-15       Impact factor: 8.551

Review 6.  Autoimmune bullous dermatoses in the elderly: diagnosis and management.

Authors:  Diya F Mutasim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management.

Authors:  Diya F Mutasim
Journal:  Drugs Aging       Date:  2010-01-01       Impact factor: 3.923

Review 8.  Desmoglein as a target in skin disease and beyond.

Authors:  Masayuki Amagai; John R Stanley
Journal:  J Invest Dermatol       Date:  2011-12-22       Impact factor: 8.551

9.  Endemic pemphigus over a century: Part II.

Authors:  Ana María Abréu-Vélez; Ana Maria Roselino; Michael S Howard; Iara J de Messias Reason
Journal:  N Am J Med Sci       Date:  2010-03

10.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.